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LETTER
Mitochondrial Dysfunction and Decrease in
Body Weight of Transgenic Knock-in
Mouse Model for TDP-43: the Question of
Glucose?
Stribl et al. (1) observed 10% reduction in body weight and an altered
lipid profile in a TDP-43 knock-in mouse model. These observations
complement the emerging hypothesis that metabolic abnormalities
are characteristic of TDP-43 proteinopathies, notably amyotrophic
lateral sclerosis (ALS) (2). However, there are a number of inconsis-
tencies in their observations and the data fromALS patients. Further-
more, we have some reservations about the interpretation of some of
the data.
In the Summary and under “Discussion,” Stribl et al. (1) mention that
TDP-43 heterozygous mutants have an increase of glucose in the
blood. However, Fig. 7 shows no difference in the level of blood glu-
cose in either fasted or ad libitum fed mutant mice when compared
with controls (1). Additionally, since pre-morbid diabetes mellitus
delays the onset of ALS by 4 years (2), an increase in glucose is
expected to be beneficial rather than detrimental in ALS models, an
effect that has also been shown in TDP-43 Caenorhabditis elegans
models (3). Further, Stribl et al. (1) demonstrate that the morphology
and function of mitochondria are impaired in TDP-43 mutant mice.
Hence, hypoglycemia rather than hyperglycemia is expected, because
under mitochondrial impairment, the rate of glucose consumption
through glycolysis is increased. Indeed, hypoglycemia is a feature of
many mitochondrial disorders (4). One of the most probable reasons
for increased blood glucose in TDP-43 knock-in mice is increased
resistance to insulin, a feature of hypermetabolism observed in some
ALS patients (5). To address this possibility, analyses of glucose and
insulin tolerance would be essential.
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